Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt 0.04
REMI's Cash-to-Debt is ranked lower than
99% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. REMI: 0.04 )
Ranked among companies with meaningful Cash-to-Debt only.
REMI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.17 Max: 20.32
Current: 0.04
0
20.32
Equity-to-Asset 0.41
REMI's Equity-to-Asset is ranked lower than
74% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. REMI: 0.41 )
Ranked among companies with meaningful Equity-to-Asset only.
REMI' s Equity-to-Asset Range Over the Past 10 Years
Min: -5.54  Med: 0.26 Max: 0.74
Current: 0.41
-5.54
0.74
Piotroski F-Score: 5
Altman Z-Score: -3.61
Beneish M-Score: -2.82
WACC vs ROIC
1.38%
-4.97%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -12.96
REMI's Operating Margin % is ranked lower than
71% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. REMI: -12.96 )
Ranked among companies with meaningful Operating Margin % only.
REMI' s Operating Margin % Range Over the Past 10 Years
Min: -61.76  Med: -13.68 Max: 2.9
Current: -12.96
-61.76
2.9
Net Margin % 5.32
REMI's Net Margin % is ranked higher than
57% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. REMI: 5.32 )
Ranked among companies with meaningful Net Margin % only.
REMI' s Net Margin % Range Over the Past 10 Years
Min: -41.65  Med: -16.24 Max: 20.25
Current: 5.32
-41.65
20.25
ROE % 5.61
REMI's ROE % is ranked higher than
52% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. REMI: 5.61 )
Ranked among companies with meaningful ROE % only.
REMI' s ROE % Range Over the Past 10 Years
Min: -140.08  Med: -51.17 Max: 27.72
Current: 5.61
-140.08
27.72
ROA % 2.23
REMI's ROA % is ranked higher than
50% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. REMI: 2.23 )
Ranked among companies with meaningful ROA % only.
REMI' s ROA % Range Over the Past 10 Years
Min: -52.71  Med: -16.09 Max: 8.27
Current: 2.23
-52.71
8.27
ROC (Joel Greenblatt) % 3.53
REMI's ROC (Joel Greenblatt) % is ranked lower than
58% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. REMI: 3.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
REMI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -136.04  Med: -29.08 Max: 71.93
Current: 3.53
-136.04
71.93
3-Year Revenue Growth Rate -1.80
REMI's 3-Year Revenue Growth Rate is ranked lower than
69% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. REMI: -1.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
REMI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -50.3  Med: -10.35 Max: 61.1
Current: -1.8
-50.3
61.1
GuruFocus has detected 1 Warning Sign with Remedent Inc $REMI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» REMI's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with REMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339114    SIC: 3843
Compare:NAS:SSKN, OTCPK:PEYE, NAS:NURO, OTCPK:ECIA, OTCPK:VPTDF, OTCPK:RSCF, NAS:DXTR, OTCPK:UNISQ, OTCPK:SOAN, OTCPK:QTXB, OTCPK:UEEC, NAS:SKLN, OTCPK:ASNB, OTCPK:WHSI, OTCPK:GNID, OTCPK:IGAP, NAS:AKER, OTCPK:STXS, OTCBB:NEPH, OTCPK:REPR » details
Headquarter Location:Belgium
Remedent Inc is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products.

Remedent, Inc. was originally incorporated under the laws of Arizona in September 1996 under the name Remedent USA, Inc. The Company designs, develops, manufactures and distributes cosmetic dentistry products. Its products are distributed in Europe, Asia, Middle East and the United States. It currently has three primary products: 'River 8' veneer, a 'prefab' veneer, Whitening Products and GlamSmile Veneers. The Company manufactures products in its facility in Ghent, Belgium, as well as through outsourced manufacturing in Ghent, China and France. As it markets dental products which are legally defined to be medical devices, it is considered to be a medical device manufacturer and as such it is subject to the regulations of, among other governmental entities, the United States Food and Drug Administration and the corresponding agencies of the states and foreign countries in which it sells its products.

Ratios

vs
industry
vs
history
PE Ratio 16.00
REMI's PE Ratio is ranked higher than
87% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. REMI: 16.00 )
Ranked among companies with meaningful PE Ratio only.
REMI' s PE Ratio Range Over the Past 10 Years
Min: 5.67  Med: 13.42 Max: 99999999.99
Current: 16
5.67
99999999.99
PE Ratio without NRI 16.00
REMI's PE Ratio without NRI is ranked higher than
87% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. REMI: 16.00 )
Ranked among companies with meaningful PE Ratio without NRI only.
REMI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.67  Med: 13.17 Max: 99999999.99
Current: 16
5.67
99999999.99
Price-to-Owner-Earnings 24.62
REMI's Price-to-Owner-Earnings is ranked higher than
71% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. REMI: 24.62 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
REMI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.59  Med: 22.31 Max: 120
Current: 24.62
4.59
120
PB Ratio 2.70
REMI's PB Ratio is ranked higher than
64% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. REMI: 2.70 )
Ranked among companies with meaningful PB Ratio only.
REMI' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.88 Max: 44
Current: 2.7
1.01
44
PS Ratio 2.64
REMI's PS Ratio is ranked higher than
61% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. REMI: 2.64 )
Ranked among companies with meaningful PS Ratio only.
REMI' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 1.24 Max: 9.1
Current: 2.64
0.29
9.1
Price-to-Operating-Cash-Flow 80.00
REMI's Price-to-Operating-Cash-Flow is ranked lower than
91% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. REMI: 80.00 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
REMI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.96  Med: 15.79 Max: 1525
Current: 80
2.96
1525
EV-to-EBIT 126.92
REMI's EV-to-EBIT is ranked lower than
96% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. REMI: 126.92 )
Ranked among companies with meaningful EV-to-EBIT only.
REMI' s EV-to-EBIT Range Over the Past 10 Years
Min: -34.2  Med: -4.8 Max: 1245.6
Current: 126.92
-34.2
1245.6
EV-to-EBITDA 37.52
REMI's EV-to-EBITDA is ranked lower than
85% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. REMI: 37.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
REMI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -102.6  Med: -3.95 Max: 103.8
Current: 37.52
-102.6
103.8
Current Ratio 0.80
REMI's Current Ratio is ranked lower than
96% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. REMI: 0.80 )
Ranked among companies with meaningful Current Ratio only.
REMI' s Current Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.91 Max: 3.7
Current: 0.8
0.11
3.7
Quick Ratio 0.70
REMI's Quick Ratio is ranked lower than
90% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. REMI: 0.70 )
Ranked among companies with meaningful Quick Ratio only.
REMI' s Quick Ratio Range Over the Past 10 Years
Min: 0.03  Med: 0.74 Max: 3.07
Current: 0.7
0.03
3.07
Days Inventory 199.89
REMI's Days Inventory is ranked lower than
79% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. REMI: 199.89 )
Ranked among companies with meaningful Days Inventory only.
REMI' s Days Inventory Range Over the Past 10 Years
Min: 91.02  Med: 178.69 Max: 300.89
Current: 199.89
91.02
300.89
Days Sales Outstanding 140.12
REMI's Days Sales Outstanding is ranked lower than
87% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. REMI: 140.12 )
Ranked among companies with meaningful Days Sales Outstanding only.
REMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.58  Med: 89.17 Max: 140.12
Current: 140.12
31.58
140.12
Days Payable 431.09
REMI's Days Payable is ranked higher than
98% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. REMI: 431.09 )
Ranked among companies with meaningful Days Payable only.
REMI' s Days Payable Range Over the Past 10 Years
Min: 77.14  Med: 174.55 Max: 431.09
Current: 431.09
77.14
431.09

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 2.67
REMI's Price-to-Tangible-Book is ranked higher than
75% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. REMI: 2.67 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
REMI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.3  Med: 3.06 Max: 45.31
Current: 2.67
1.3
45.31
Price-to-Median-PS-Value 2.13
REMI's Price-to-Median-PS-Value is ranked lower than
80% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. REMI: 2.13 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
REMI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 0.93 Max: 4.62
Current: 2.13
0.22
4.62
Price-to-Graham-Number 1.33
REMI's Price-to-Graham-Number is ranked higher than
83% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. REMI: 1.33 )
Ranked among companies with meaningful Price-to-Graham-Number only.
REMI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.71  Med: 1.25 Max: 2.62
Current: 1.33
0.71
2.62
Earnings Yield (Greenblatt) % 0.80
REMI's Earnings Yield (Greenblatt) % is ranked lower than
65% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. REMI: 0.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
REMI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 5.7 Max: 20.8
Current: 0.8
0.1
20.8

More Statistics

Revenue (TTM) (Mil) $2.41
EPS (TTM) $ 0.02
Beta0.02
Short Percentage of Float0.00%
52-Week Range $0.10 - 0.40
Shares Outstanding (Mil)20.00

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)